Gastrointestinal pirfenidone adverse events in idiopathic pulmonary fibrosis depending on diet: the MADIET clinical trial

Individuals with IPF who follow a MUFA diet report a lower incidence of pirfenidone gastrointestinal adverse events than those that follow a SFA diet, which could explain the different prevalence in GI pirfenidone AEs reported by countries in IPF cohorts https://bit.ly/3LuzAUJ

Detalles Bibliográficos
Autores principales: Molina-Molina, Maria, Shull, Jessica Germaine, Vicens-Zygmunt, Vanesa, Rivera-Ortega, Pilar, Antoniou, Katerina, Bonella, Francesco, Renzoni, Elisabetta, Russell, Anne-Marie, Maher, Toby M., Vancheri, Ada, Bachs, Anna, Avilés, Victoria, Palma, Josep, Bermudo, Guadalupe, Suarez-Cuartin, Guillermo, Tebé, Cristian, Rigo-Bonnin, Raul, Montes-Worboys, Ana, Wijsenbeek, Marlies, Vancheri, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586233/
https://www.ncbi.nlm.nih.gov/pubmed/37857429
http://dx.doi.org/10.1183/13993003.00262-2023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586233/
https://www.ncbi.nlm.nih.gov/pubmed/37857429
http://dx.doi.org/10.1183/13993003.00262-2023

Ejemplares similares